Lv31
274 积分 2022-09-05 加入
Clinical features and prognostic factors of primary gastrointestinal lymphoma
7小时前
求助中
Molecular Features of Response and Resistance to Glofitamab, a T-Cell Engager for treatment of Large B-Cell Lymphoma
1个月前
已关闭
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
2个月前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
3个月前
已完结
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?
4个月前
已完结
Building the future management of follicular lymphoma with T-cell–redirecting strategies
4个月前
已完结
Frontline treatment of follicular lymphoma: What will it take to change current practice?
4个月前
已完结
The future of follicular lymphoma management: strategies on the horizon
4个月前
已完结
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?
4个月前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
6个月前
已完结
皖公网安备34019202002308